Teva Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TEVA and other ETFs, options, and stocks.

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. 

CEO
Richard Francis
CEORichard Francis
Employees
36,167
Employees36,167
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
1901
Founded1901
Employees
36,167
Employees36,167

TEVA Key Statistics

Market cap
30.82B
Market cap30.82B
Price-Earnings ratio
42.99
Price-Earnings ratio42.99
Dividend yield
Dividend yield
Average volume
10.54M
Average volume10.54M
High today
$26.96
High today$26.96
Low today
$26.28
Low today$26.28
Open price
$26.48
Open price$26.48
Volume
9.05M
Volume9.05M
52 Week high
$26.96
52 Week high$26.96
52 Week low
$12.47
52 Week low$12.47

Stock Snapshot

The current Teva Pharmaceutical(TEVA) stock price is $26.89, with a market capitalization of 30.82B. The stock trades at a price-to-earnings (P/E) ratio of 42.99.

On 2025-11-29, Teva Pharmaceutical(TEVA) stock moved within a range of $26.28 to $26.96. With shares now at $26.89, the stock is trading +2.3% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 9.05M, compared to an average daily volume of 10.54M.

The stock's 52-week range extends from a low of $12.47 to a high of $26.96.

The stock's 52-week range extends from a low of $12.47 to a high of $26.96.

TEVA News

Simply Wall St 2d
Teva Pharmaceutical Industries: Evaluating Valuation After European Approval for Key Biosimilars

Teva Pharmaceutical Industries (NYSE:TEVA) has received European Commission approval for its biosimilars PONLIMSI and DEGEVMA. This development strengthens its...

Teva Pharmaceutical Industries: Evaluating Valuation After European Approval for Key Biosimilars
Simply Wall St 3d
Teva Rise Innovation Platform Might Change The Case For Investing In Teva Pharmaceutical Industries

Earlier this week, Teva Pharmaceutical Industries launched Teva Rise, a global open innovation platform designed to connect startups and technology companies wi...

Teva Rise Innovation Platform Might Change The Case For Investing In Teva Pharmaceutical Industries

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.